Back to library

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

GLP-1 Agonist · Metabolic

Exenatide (Byetta / Bydureon)

First-in-class GLP-1 receptor agonist for type 2 diabetes.

FDA-Approved

Plain-Language Label Highlights

Brand names: Byetta, Bydureon BCise

What it's approved for

Type 2 diabetes — twice-daily (Byetta) or weekly (Bydureon).

A GLP-1 injection that lowers blood sugar after meals by slowing digestion and increasing insulin response.

Boxed Warning

Bydureon: thyroid C-cell tumor risk — avoid with medullary thyroid cancer or MEN 2.

Common side effects
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Injection-site nodules (weekly form)
Serious risks to know
  • Pancreatitis
  • Kidney injury
  • Severe hypoglycemia with sulfonylureas
Who should avoid or use with extra caution
  • Severe kidney disease (eGFR <45)
  • Severe GI disease
  • Medullary thyroid cancer history (Bydureon)

Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.

Mechanism of Action

Synthetic version of exendin-4 (originally from Gila monster saliva). Activates GLP-1 receptors to enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and increase satiety.

Research Areas

Type 2 diabetes
Weight management (off-label)

Common Research Protocols

Byetta

5–10 mcg SC twice daily.

Bydureon (extended release)

2 mg SC once weekly.

Protocols summarized for educational reference from published research. Not dosing guidance.

Cited Research

[1]NEJM·2017

EXSCEL trial

Cardiovascular safety established for once-weekly exenatide.

Important Considerations

  • FDA-approved.
  • Nausea common; pancreatitis warning.

Explore more peptides

Educational Information Only — Not Medical Advice

All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.

Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.

Searching the library…

Ask the Library

Ask anything about peptides — answers come from our curated reference library with citations.

Find a pharmacy that carries Exenatide (Byetta / Bydureon)

Leave your details and a vetted partner pharmacy will reach out with availability and pricing.